Table of Contents Author Guidelines Submit a Manuscript

Chemotherapy-Induced Neuropathic Pain: From Bench to Bedside

Call for Papers

In recent years, chemotherapeutic therapies have steadily decreased mortality among cancer patients. Unfortunately, most of these molecules may also induce severe chronic pain states that can alter treatment adherence and quality of life among surviving patients. Although chemotherapy-induced neuropathic pain is a common adverse effect, little is known about its physiopathology and thus is still considered a difficult to treat disease. Taking this fact into account, translational research addressing both novel mechanism-based treatment and clinical correlations on basic demonstrated pathophysiologic mechanisms should be encouraged.

This special issue seeks to cover chemotherapy-induced pain related basic, clinical, or translational research. Investigators are cordially invited to submit a high-quality review or research articles that may improve our understanding on chemotherapy-induced neuropathic pain pathophysiology, novel therapeutic approaches, and current epidemiology and therapeutic success. Higher priority will be given to translational protocols regarding chemotherapy-induced neuropathic pain, quality of life assessments, and basic research involving both conduct and molecular models.

Potential topics include but are not limited to the following:

  • Novel insights on pathophysiologic mechanisms of chemotherapy-induced neuropathic pain
  • Neuroimmunological modulation for prevention or treatment of chemotherapy-induced neuropathic pain
  • Cortical rearrangement induced by chemotherapeutic agents
  • Quality of life association to chemotherapy-induced pain in surviving cancer patients
  • Current therapeutic approaches and their effectiveness
  • Epidemiology of chemotherapy-induced neuropathic pain
  • Translational approaches in chemotherapy-induced neuropathic pain treatment
  • New approaches and alternative treatments for chemotherapy-induced neuropathic pain

Authors can submit their manuscripts through the Manuscript Tracking System at

Submission DeadlineFriday, 1 December 2017
Publication DateApril 2018

Papers are published upon acceptance, regardless of the Special Issue publication date.

Lead Guest Editor

  • Ulises Coffeen, Instituto Nacional de Psiquiatría Ramón de la Fuente Muñíz, Mexico City, Mexico

Guest Editors